An artist's view of drug-induced hallucinosis.
The occurrence of hallucinations in patients with Parkinson's disease is often related to antiparkinsonian therapy, but other factors such as cognitive decline and sleep-cycle disturbances are thought to contribute. We describe an artist who depicted her visual hallucinations experienced in the course of Parkinson's disease.
Ebersbach
Georg
G
Fachkrankenhaus für Bewegungsstörungen/Parkinson, Beelitz-Heilstätten, Germany. ebersbach@gesundheitspark.com
D000547:Amantadine / Q000008:administration & dosage / Q000009:adverse effects*; D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D006212:Hallucinations / Q000139:chemically induced* / Q000523:psychology; D006801:Humans; D008512:Medicine in the Arts; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy* / Q000523:psychology; D010469:Perceptual Distortion / Q000187:drug effects; D010781:Photography
D000978:Antiparkinson Agents; D000547:Amantadine